Technology
Health
Biotechnology

Axcella Health

$7.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (4.08%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Axcella Health and other stocks, options, ETFs, and crypto commission-free!

About AXLA

Axcella Health Inc. Common Stock, also called Axcella Health, is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. Read More Its product pipeline includes AXA1665, AXA1125, AXA1957, AXA2678, and AXA4010. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.

Employees
49
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
182.58M
Price-Earnings Ratio
Dividend Yield
Average Volume
13.56K
High Today
$7.89
Low Today
$7.43
Open Price
$7.61
Volume
2.49K
52 Week High
$20.00
52 Week Low
$6.10

Collections

Technology
Health
Biotechnology
Research And Development
2019 IPO
US
North America

AXLA Earnings

-$2.43
-$1.94
-$1.44
-$0.95
Q1 2019
Q2 2019
Estimated
Actual
-$0.95 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.